RJR News / Indies Pharma Jamaica’s Initial Public Offering has been oversubscribed.   The trading that  closed  on Friday was for 266.5 million shares valued at $1.50 cents each .   Indies Pharma Jamaica, which is a Montego Bay-based pharmaceutical company, intends to apply for listing on the junior market of  the Jamaica Stock Exchange.


View all posts